Northern Trust’s Dogwood Therapeutics DWTX Stock Holding History

Northern Trust’s Portfolio DWTX Stock Details DWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$50.2K	Buy	+23,779	New	+$70K	﹤0.01%	4243
2024 Q4	–	Sell	-961	Closed	-$4.09K	–	4497
2024 Q3	$4.09K	Hold	961	–	–	﹤0.01%	4404
2024 Q2	$5.17K	Hold	961	–	–	﹤0.01%	4403
2024 Q1	$11.5K	Hold	961	–	–	﹤0.01%	4379
2023 Q4	$13.8K	Hold	961	–	–	﹤0.01%	4397
2023 Q3	$22.2K	Hold	961	–	–	﹤0.01%	4314
2023 Q2	$33.2K	Buy	961 +328	+52%	+$9.36K	﹤0.01%	4309
2023 Q1	$5.82K	Hold	633	–	–	﹤0.01%	4559
2022 Q4	$3.74K	Hold	633	–	–	﹤0.01%	4635
2022 Q3	$6K	Hold	633	–	–	﹤0.01%	4672
2022 Q2	$67K	Buy	633 +28	+5%	+$2.93K	﹤0.01%	4322
2022 Q1	$68K	Hold	605	–	–	﹤0.01%	4457
2021 Q4	$77K	Buy	+605	New	+$77K	﹤0.01%	4498

Other funds holding DWTX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AWM

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust's DWTX Position: Q1 2026 in Review

Northern Trust opened a new position in Dogwood Therapeutics (DWTX) in Q1 2026: 23,779 shares worth $50.2K. The stake represents ﹤0.01% of the portfolio and ranks #4243 among its holdings. This is a return to the name: Northern Trust previously reported a position in DWTX as recently as Q3 2024.

Northern Trust first reported a position in DWTX in Q4 2021 and has held it in 13 quarters since. The position peaked at $77K in Q4 2021. 13 funds tracked by Wall St. Rank hold DWTX as of Q1 2026.

Northern Trust held 23,779 shares of Dogwood Therapeutics worth $50.2K as of Q1 2026.
Dogwood Therapeutics was a new Northern Trust position in Q1 2026.
Dogwood Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4243 holding.
Northern Trust first reported a position in Dogwood Therapeutics in Q4 2021 and has held it in 13 quarters since.
Northern Trust's Dogwood Therapeutics position peaked at $77K in Q4 2021.
13 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.